RXRX — Recursion Pharmaceuticals, Inc.

Ownership history in Data Collective IV GP, LLC  ·  15 quarters on record

AI Ownership Summary

Data Collective IV GP, LLC reported Recursion Pharmaceuticals, Inc. (RXRX) in 15 quarterly 13F filings from 2023 Q3 through 2025 Q4. Peak portfolio weight reached 51.36% in 2024 Q1. The latest visible filing shows RXRX at 41.53% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this RXRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Data Collective IV GP, LLC's position in Recursion Pharmaceuticals, Inc., and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

RXRX was reported at 41.53% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
51.36% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

RXRX stock page Data Collective IV GP, LLC fund profile Data Collective IV GP, LLC full holdings
How Data Collective IV GP, LLC held RXRX — position size vs. price
% of Fund (quarterly)    RXRX price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 5,941,120 — 0% 41.53% $24.3M 2026-02-14 (Est.) $3.49
2025 Q3 UNCHANGED 5,941,120 — 0% 42.65% $29.0M 2025-11-14 $4.14
2025 Q2 UNCHANGED 5,941,120 — 0% 23.14% $30.1M 2025-08-14 $5.64
2025 Q1 UNCHANGED 5,941,120 — 0% 36.17% $31.4M 2025-05-15 $4.25
2024 Q4 UNCHANGED 5,941,120 — 0% 17.75% $40.2M 2025-02-14 $10.53
2024 Q3 UNCHANGED 5,941,120 — 0% 23.95% $39.2M 2024-11-14 $6.91
2024 Q2 UNCHANGED 5,941,120 — 0% 31.23% $44.6M 2024-08-14 $6.28
2024 Q1 UNCHANGED 5,941,120 — 0% 51.36% $59.2M 2024-05-15 $10.01
2023 Q4 UNCHANGED 5,941,120 — 0% 48.46% $58.6M 2024-02-14 $10.92
2023 Q3 UNCHANGED 5,941,120 — 0% 43.00% $45.4M 2023-11-14 $6.46
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding RXRX

As of 2025 Q4 — sorted by position size

DCVC Opportunity Fund II GP, LLC 3Y 97.42% MIC Capital Management UK LLP 3Y 8.94% Nan Fung Group Holdings Ltd 3Y 2.18% ARK Investment Management LLC 3Y 7Y 1.01% Pivotal bioVenture Partners Investment Advisor LLC 3Y 0.94% Carroll Investors, Inc 3Y 0.79% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 0.68% Green Alpha Advisors, LLC 3Y 0.57% DIADEMA PARTNERS LP 0.52% SOFTBANK GROUP CORP. 3Y 0.36%

FAQ About Data Collective IV GP, LLC and RXRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Data Collective IV GP, LLC reported owning RXRX?

Data Collective IV GP, LLC reported RXRX across 10 quarterly 13F filings, from 2023 Q3 through 2025 Q4.

What was the largest reported RXRX position in Data Collective IV GP, LLC's portfolio?

The largest reported portfolio weight for RXRX was 51.36% in 2024 Q1.

What is the latest reported RXRX position on this page?

The most recent filing on this page is 2025 Q4, when Data Collective IV GP, LLC reported 5,941,120 shares, equal to 41.53% of portfolio, with an estimated market value of $24.3M.

What does the chart on this RXRX ownership page compare?

The chart compares Data Collective IV GP, LLC's quarterly RXRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Data Collective IV GP, LLC Holdings